Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acorn Biolabs is a personalized regenerative medicine company that provides a non-invasive solution for preserving live cells for future medical use. The company specializes in banking hair follicle cells, which are rich in stem cells and can be easily collected without surgery. These cryopreserved cells serve as a biological resource for future regenerative therapies, including skin rejuvenation, hair loss treatments, and potentially more complex gene and cell therapies as medical technology advances. By banking younger cells today, Acorn aims to provide individuals with a high-quality source of their own genetic material for personalized healthcare in the future.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acorn Foundation.